1. Global initiative for chronic obstructive lung disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO work-shop report. Last updated 2011. www.gold copd.org
2. Hardie J.A., Buist A.S., Vollmer W.M. et al. Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur. Respir. J. 2002; 20 (5): 1117-1122.
3. Hwang Y.I., Kim C.H., Kang H.R. et al. Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J. Korean Med. Sci. 2009; 24 (4): 621-626.
4. Aggarwal A.N., Gupta D., Agarwal R., Jindal S.K. Comparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice. Respir. Care 2011; 56: 1778-1784.
5. Calverley P.M., Burge P.S., Spencer S. et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664.
6. Tierney D.F., Nadel J.A. Concurrent measurements of functional residual capacity by three methods. J. Appl. Physiol. 1962, 17: 871-873.
7. Pare P.D., Wiggs B.J., Coppin C.A. Errors in the measurement of total lung capacity in chronic obstructive lung disease. Thorax 1983, 38: 468-471.
8. Черняк А.В., Авдеев С.Н., Пашкова Т.Л., Айсанов З.Р. Бронходилатационный тест у больных с хронической обструктивной болезнью легких. Пульмонология 2003; 1: 51-56.
9. O'Donnell D.E., Lam M., Webb K.A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 542-549.
10. Casanova C., Cote C., de Torres J.P. et al. Inspiratory-tototal lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 171: 591-597.
11. Поливанов Г.Э. Структурно-денситометрический анализ ткани легких у больных ХОБЛ: Автореф. дис. … канд. мед. наук. М.; 2008.
12. Palange P., Ward S.A., Carlsen K.H. et al. Recommendations on the use of exercise testing in clinical practice. Eur. Respir. J. 2007; 29 (1): 185-209.
13. Oga T., Nishimura K., Tsukino M. et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am. J. Respir. Crit. Care Med. 2003; 167: 544-549.
14. Enright P.L., Sherrill D.L. Reference equations for the sixminute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998. 158: 1384-1387.
15. Cote C.G., Pinto,Plata V., Kasprzyk K. et al. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007; 132 (6): 1778-1785.
16. Casas A., Vilaro J., Rabinovich R. et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005; 128 (1): 55-61.
17. Cahalin L., Pappagianopoulos P., Prevost S. et al. The relationship of th 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest 1995; 108: 452-459.
18. Celli B.R., Cote C.G., Marin J.M. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005-1012.
19. Celli B.R., Cote C.G., Lareau S.C., Meek P.M. Predictors of Survival in COPD: more than just the FEV1. Respir. Med. 2008; 102 (Suppl. 1): S27-S35.
Послать статью по эл. почте 